What is the current size of the global eClinical solutions market?

The global eClinical solutions market size was valued at USD 10.5 billion in 2024 and expected to reach USD 35.01 billion by 2034. Read More

What is the CAGR of eClinical solutions market?

The global eClinical solutions market is poised to grow at a compound annual growth rate (CAGR) 12.8% during the forecast period 2024 to 2034. Read More

What are the growth factors of eClinical solutions market?

Increase in the number of customers adopting eClinical solutions, rising Research and Development (R&D), and rise in government grants to authorize the clinical trials. These solutions are also used in clinical studies where electronic applications enabled with web tools are used to capture the real-time data from clinical trials that provide superior execution and escalate the eClinical solutions market growth. Read More

Why North America held significant value share in the global eClinical solutions market?

In 2019, North America held significant value share in the global eClinical solutions market owing to increase in the number of clinical trials in the region. Further, rising government grants for clinical trials, huge funding in R&D activities, technological advancements, along with significant rise in the lifestyle associated diseases are the key factors that propel the industry growth. Read More

Which region hit strongest CAGR over the forecast period?

The Asia Pacific encountered an escalating CAGR over the forecast timespan due to the rising investment in R&D. Read More

Which key players operating in the eClinical solutions market?

Some of the key players operating in the market are PAREXEL International, Oracle Corp., Bioclinica, Medidata Solution, DATATRAK, ERT Clinical, CRF Health, eClinicalWorks, OmniComm Systems, IBM Watson Health, and eClinical Solutions among others. Read More

Which segment accounted for the largest eClinical solutions market share?

Electronic Clinical Outcome Assessment (eCOA) estimated to be the fastest growing product segment over the analysis period due to rising importance of high-quality clinical data. Read More

Which delivery mode segment exhibit strong growth in the eClinical solutions market?

Cloud-based solutions predicted to exhibit strong growth during the analysis period due to integrated features such as high accessibility, flexibility, and easy data backup. Read More

eClinical Solutions Market Size, Share, and Trends 2024 to 2034

The global eClinical solutions market size is estimated at USD 10.5 billion in 2024, grew to USD 11.84 billion in 2025 and is predicted to surpass around USD 35.01 billion by 2034, expanding at a CAGR of 12.80% between 2024 and 2034. The North America eClinical solutions market size accounted for USD 5.46 billion in 2024 and is anticipated to grow at a fastest CAGR of 5.46% during the forecast year.

Last Updated : July 2023
Report Code : 1092
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global eClinical Solutions Market, By Product

7.1. eClinical Solutions Market, by Product Type, 2024-2034
7.1.1. EDC & CDMS
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. eCOA
7.1.2.1. Market Revenue and Forecast (2021-2034)
7.1.3. Clinical Data Integration Platforms
7.1.3.1. Market Revenue and Forecast (2021-2034)
7.1.4. CTMS
7.1.4.1. Market Revenue and Forecast (2021-2034)
7.1.5. Safety Solutions
7.1.5.1. Market Revenue and Forecast (2021-2034)
7.1.6. RTSM
7.1.6.1. Market Revenue and Forecast (2021-2034)
7.1.7. Clinical Analytics platforms
7.1.7.1. Market Revenue and Forecast (2021-2034)
7.1.8. eTMF
7.1.8.1. Market Revenue and Forecast (2021-2034)

Chapter 8. Global eClinical Solutions Market, By Development Phase

8.1. eClinical Solutions Market, by Development Phase, 2024-2034
8.1.1. Phase IV
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Phase III
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Phase II
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Phase I
8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global eClinical Solutions Market, By Delivery Mode

9.1. eClinical Solutions Market, by Delivery Mode, 2024-2034
9.1.1. Licensed Enterprise
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Web-hosted
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Cloud-based
9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global eClinical Solutions Market, By End-Use

10.1. eClinical Solutions Market, by End-Use, 2024-2034
10.1.1. CROs
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Academic Institutes
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Medical Device Manufacturers
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Pharma & Biotech Organizations
10.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global eClinical Solutions Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.1.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.1.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.1.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.6.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.1.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.1.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.2.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.2.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.2.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.2.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.2.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.8.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.2.8.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.2.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.3.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.3.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.3.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.3.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.3.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.8.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.3.8.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.3.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.4.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.4.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.4.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.4.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.4.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.8.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.4.8.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.4.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.5.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.6.2. Market Revenue and Forecast, by Development Phase (2021-2034)
11.5.6.3. Market Revenue and Forecast, by Delivery Mode (2021-2034)
11.5.6.4. Market Revenue and Forecast, by End-Use (2021-2034)

Chapter 12. Company Profiles

12.1. PAREXEL International
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Oracle Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Bioclinica
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medidata Solution
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. DATATRAK
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ERT Clinical
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CRF Health
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. eClinicalWorks
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OmniComm Systems
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. IBM Watson Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. eClinical Solutions
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

We use cookies to improve your experience

eClinical Solutions Market Size To Hit USD 35.01 Bn by 2034

List of Contents